36 related articles for article (PubMed ID: 15379558)
21. Tertiary structure of thiopurine methyltransferase from Pseudomonas syringae, a bacterial orthologue of a polymorphic, drug-metabolizing enzyme.
Scheuermann TH; Lolis E; Hodsdon ME
J Mol Biol; 2003 Oct; 333(3):573-85. PubMed ID: 14556746
[TBL] [Abstract][Full Text] [Related]
22. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.
Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I
Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339
[TBL] [Abstract][Full Text] [Related]
23. The 2.2 A structure of the rRNA methyltransferase ErmC' and its complexes with cofactor and cofactor analogs: implications for the reaction mechanism.
Schluckebier G; Zhong P; Stewart KD; Kavanaugh TJ; Abad-Zapatero C
J Mol Biol; 1999 Jun; 289(2):277-91. PubMed ID: 10366505
[TBL] [Abstract][Full Text] [Related]
24. Post-translational stabilization of thiopurine S-methyltransferase by S-adenosyl-L-methionine reveals regulation of TPMT*1 and *3C allozymes.
Milek M; Smid A; Tamm R; Kuzelicki NK; Metspalu A; Mlinaric-Rascan I
Biochem Pharmacol; 2012 Apr; 83(7):969-76. PubMed ID: 22274639
[TBL] [Abstract][Full Text] [Related]
25. Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: implications for RNA-capping mechanisms in Flavivirus.
Bollati M; Milani M; Mastrangelo E; Ricagno S; Tedeschi G; Nonnis S; Decroly E; Selisko B; de Lamballerie X; Coutard B; Canard B; Bolognesi M
J Mol Biol; 2009 Jan; 385(1):140-52. PubMed ID: 18976670
[TBL] [Abstract][Full Text] [Related]
26. Consequences of binding an S-adenosylmethionine analogue on the structure and dynamics of the thiopurine methyltransferase protein backbone.
Scheuermann TH; Keeler C; Hodsdon ME
Biochemistry; 2004 Sep; 43(38):12198-209. PubMed ID: 15379558
[TBL] [Abstract][Full Text] [Related]
27. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.
Wang L; Weinshilboum R
Oncogene; 2006 Mar; 25(11):1629-38. PubMed ID: 16550163
[TBL] [Abstract][Full Text] [Related]
28. Drug methylation in cancer therapy: lessons from the TPMT polymorphism.
Krynetski E; Evans WE
Oncogene; 2003 Oct; 22(47):7403-13. PubMed ID: 14576848
[TBL] [Abstract][Full Text] [Related]
29. Characterization of enzyme motions by solution NMR relaxation dispersion.
Loria JP; Berlow RB; Watt ED
Acc Chem Res; 2008 Feb; 41(2):214-21. PubMed ID: 18281945
[TBL] [Abstract][Full Text] [Related]
30. Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms.
Li J; Sun C; Cai W; Li J; Rosen BP; Chen J
Mutat Res Rev Mutat Res; 2021; 788():108396. PubMed ID: 34893161
[TBL] [Abstract][Full Text] [Related]
31. SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold.
Martin JL; McMillan FM
Curr Opin Struct Biol; 2002 Dec; 12(6):783-93. PubMed ID: 12504684
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
